MKC Biotherapeutics, Inc
- Biotech or pharma, therapeutic R&D
MKC Biotherapeutics is a therapeutics company, operationalized in June 2024. The company is focused on regenerative medicine applications using "disease modifying"cell-based drugs for treatment of chronic & age-related diseases. Our business model is to identify & in-license therapeutic platforms / product assets with demonstrated human safety & efficacy data (with durable clinical benefit) and undertake any required bridging clinical / regulatory development for purposes of commercial marketing approval in US & Europe.
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}